Hadassah

Hadassah: Renowned in Noninvasive Removal of Kidney Stones

Wednesday, Jan 9 2013

One of the first hospitals in the world to acquire a lithotripter--which revolutionized the elimination of kidney stones with noninvasive shock wave therapy—the Hadassah Medical Center today houses the largest Kidney Stone Treatment Center in Israel.

Since 1985 when Hadassah began treating patients with shock wave lithotripsy, the Center has retired its first unit, replacing it in August 2010 with the more sophisticated Dornier Gemini lithotripter. The new machine causes less discomfort to patients and requires milder sedation. Where previously patients needed to be placed in a special bath for the treatment, they now undergo the hour procedure fully clothed, lying on a bed.

Hadassah's lithotripsy patients have ranged from a five-year-old girl who had a large stone in her right kidney, to a middle-aged woman with a renal pelvis stone, to a 107-year-old man who developed a stone in the upper part of his ureter. The middle-aged woman had been originally scheduled for surgery at another hospital to remove the stone, but decided to seek a second opinion at Hadassah. While Dr. Duvdevani, Director of Hadassah's Lithotripsy and Endo-Urology units, agreed that the size and location of the stone did make the woman a candidate for surgery, he suggested that she try one lithotripsy treatment to see if surgery could be avoided. Dr. Duvdevani dilated her ureter by inserting a stent, which also created an easier exit for the stone fragments. The lithotripsy proved successful in shattering the stone, which within four weeks passed out normally through her urine.

Dr. Duvdevani serves on a seven-member international committee that determines which medical centers throughout the world will be authorized to conduct fellowships in endo-urology, thereby shaping this specialty for the future. The Endo-Urological Society has authorized Hadassah to be the first non-American/non European Medical Center to conduct fellowships in endo-urology. The first fellow to train at Hadassah is a physician from India.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›
alt_text

Friday, Aug 2 2019

Eloxx Pharmaceuticals Announces New Drug Application for Clinical Trial in Cystic Fibrosis Patients

Professor Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Organization, will serve as the Global Lead Investigator for this clinical trial.

READ MORE ›
alt_text

Wednesday, Jul 31 2019

Skin Cancer Treatment Enhanced in New Center for Dermatologic Surgery

Thanks to a donation by the Israeli businessman and philanthropist Morris Kahn, a major supporter of the Israeli moon spacecraft “Beresheet,” Hadassah Hospital Ein Kerem has just opened the new Center for Dermatologic Surgery, which offers Mohs surgery for patients with common types of skin cancer.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More